IVAX Awarded Large Antibiotic Contract From U.S. Government.Business Editors/Health & Medical Writers
MIAMI--(BUSINESS WIRE)--Oct. 26, 2001
IVAX Corporation (AMEX AMEX
See: American Stock Exchange :IVX), (LSE LSE - Language Sensitive Editor :IVX.L) confirmed today that its subsidiary, IVAX IVAX Industrial Vax (Dec Computer) Pharmaceuticals, Inc., was awarded a U.S. Government contract to supply more than 1.2 billion tablets of the company's brand equivalent doxacycline 100 mg tablets and capsules. Doxacycline is one of several antibiotics used to treat anthrax.
"Filling this order is a top priority for us at this time of special concern for our country. As a leading manufacturer of antibiotics, we will, of course, make our full resources available to serve the needs required for our common welfare," said Rafick G. Henein, Ph.D., president and chief executive officer of IVAX Pharmaceuticals, Inc.
IVAX also has an application pending with the FDA FDA
Food and Drug Administration
n.pr See Food and Drug Administration.
n.pr the abbreviation for the Food and Drug Administration. for its ciprofloxacin ciprofloxacin /cip·ro·flox·a·cin/ (sip?ro-flok´sah-sin) a synthetic antibacterial effective against many gram-positive and gram-negative bacteria; used as the hydrochloride salt.
n. , the generic equivalent of Cipro(R), the antibiotic most commonly used to treat anthrax.
IVAX Corporation, headquartered in Miami, Florida, is engaged in the research, development, manufacturing, and marketing of branded and brand equivalent pharmaceuticals and veterinary and diagnostic products in the U.S. and international markets.
Copies of this and other news releases may be obtained free of charge from IVAX' web site at http://www.ivax.com.